The variables of XRCC5 (rs1051685, rs6941) were associated with hematologic toxicity in lung cancer patients treated with platinum-based chemotherapy, which means it can predict platinum-based chemotherapy toxicity in lung cancer patients [27]. Here, XRCC5 is linked to lung carcinoma.